Aligos Therapeutics Expands Executive Team
Guerbet: Guerbet Strengthens Its Executive Committee With Two New Appointments to Accelerate Its Commercial and Industrial Development
Guerbet strengthens its Executive Committee with two new appointments to accelerate its commercial and industrial development Dan Raffi appointed Director of Commercial OperationsRaoul Bernhardt appoi
BMTC Group Reports Q1 2023 Results
BMTC Group (GBT.TO), together with its subsidiaries, manages and operates a retail network of furniture, household appliances, and electronic products in Canada, on Thursday reported its Q1 2023 resul
BMTC Group Opens 11 New Stores In Quebec
BMTC Group (GBT.TO), together with its subsidiaries, manages and operates a retail network of furniture, household appliances, and electronic products in Canada, on Tuesday announced the expansion of
BMTC Group Reports Q4 EPS of $0.36
07:36 AM EDT, 04/28/2023 (MT Newswires) -- BMTC Group (GBT.TO), together with its subsidiaries, manages and operates a retail network of furniture, household appliances, and electronic products in Can
BMTC Group Reports Renewal of Normal Course Issuer Bid
06:08 AM EDT, 04/13/2023 (MT Newswires) -- BMTC Group (GBT.TO), together with its subsidiaries, manages and operates a retail network of furniture, household appliances, and electronic products in Can
BMTC Group Reports Lower Fiscal Q3 Profit, Revenue
08:15 AM EST, 12/15/2022 (MT Newswires) -- BMTC Group (GBT.TO), together with its subsidiaries, manages and operates a retail network of furniture, household appliances, and electronic products in Can
White House Says It Will Continue To Monitor Developments On Cryptocurrencies
White House Says It Will Continue To Monitor Developments On Cryptocurrencies
Guerbet: Guerbet Announces a Change in Governance for Its Artificial Intelligence Projects
Guerbet announces a change in governance for its Artificial Intelligence projects Villepinte, November 3rd, 2022: Guerbet today announced an agreement with Merative, formalizing the termination of the
BioPharma Credit Receives $175 Million From Global Blood Therapeutics Investment
02:34 AM EDT, 10/06/2022 (MT Newswires) -- BioPharma Credit (BPCR.L) said Thursday that it received $175.4 million for its $132.5 million investment in a senior secured loan to biopharmaceutical compa
Express News | Pfizer (PFE.N) announced the completion of the acquisition of Global Hematology (GBT.O).
Global Blood Therapeutics, Inc. (NASDAQ:GBT) Shares Purchased by Bank of America Corp DE
Bank of America Corp DE increased its stake in shares of Global Blood Therapeutics, Inc. (NASDAQ:GBT – Get Rating) by 16.8% during the 1st quarter, according to its most recent filing with the Secur
STOCKHOLDER ALERT: The M&A Class Action Firm Launches Merger Inquiry - RFP, SBTX, GBT, EVOP
Global Blood Therapeutics, Inc. (NASDAQ:GBT) Forecasted to Post FY2022 Earnings of ($4.55) Per Share
Global Blood Therapeutics, Inc. (NASDAQ:GBT – Get Rating) – Research analysts at Cantor Fitzgerald issued their FY2022 earnings estimates for shares of Global Blood Therapeutics in a research note
Global Blood Therapeutics (NASDAQ:GBT) Earns Neutral Rating From Cantor Fitzgerald
Cantor Fitzgerald reissued their neutral rating on shares of Global Blood Therapeutics (NASDAQ:GBT – Get Rating) in a research note issued to investors on Wednesday morning, PriceTargets.com reports
Guerbet Announces U.S. Food and Drug Administration (FDA) Approval of Elucirem™ (Gadopiclenol)
Guerbet announces U.S. Food and Drug Administration (FDA) approval of Elucirem™ (Gadopiclenol) FDA approval of EluciremTM (NDA 216986) was granted after priority review, a designation assigned to appl
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MNRL, STOR, GBT, IRBT
Pfizer to Further Tap CytoReason's AI Technology for Drug Discovery in up to $110M Deal
Pfizer (NYSE:PFE) has expanded a partnership with Israeli company CytoReason in which the latter will provide the pharma giant with artificial intelligence technology to assist in drug development. U
GBT Supports the Sickle Cell Disease Treatment Centers Act of 2022
Endurant Capital Management LP Grows Holdings in Global Blood Therapeutics, Inc. (NASDAQ:GBT)
Endurant Capital Management LP increased its holdings in shares of Global Blood Therapeutics, Inc. (NASDAQ:GBT – Get Rating) by 1.1% during the 1st quarter, according to the company in its most rece
No Data